
Impact of Flatiron’s Ingredient Drug Substitution for 505(b)(2) at Tennessee Oncology
— Case study
Tennessee Oncology streamlined formulary management and reduced manual drug substitutions using Flatiron's Ingredient Drug Substitution for 505(b)(2) drugs, improving adherence to practice and insurer preferences and reducing time to treatment.
Read case study



